| From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting MG Mumolo, L Bertani, L Ceccarelli, G Laino, G Di Fluri, E Albano, ... World journal of gastroenterology 24 (33), 3681, 2018 | 165 | 2018 |
| Thrombosis in inflammatory bowel diseases: what’s the link? M Giannotta, G Tapete, G Emmi, E Silvestri, M Milla Thrombosis Journal 13, 1-9, 2015 | 143 | 2015 |
| Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review R Sacco, G Tapete, N Simonetti, R Sellitri, V Natali, S Melissari, ... Journal of hepatocellular carcinoma, 105-110, 2017 | 62 | 2017 |
| Novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-TNF: neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio L Bertani, F Rossari, B Barberio, MG Demarzo, G Tapete, E Albano, ... Inflammatory bowel diseases 26 (10), 1579-1587, 2020 | 49 | 2020 |
| Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab L Bertani, M Fornai, M Fornili, L Antonioli, L Benvenuti, G Tapete, ... Alimentary pharmacology & therapeutics 52 (2), 284-291, 2020 | 48 | 2020 |
| Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease L Guidi, D Pugliese, TP Tonucci, L Bertani, F Costa, G Privitera, B Tolusso, ... United European gastroenterology journal 7 (9), 1189-1197, 2019 | 44 | 2019 |
| Fecal calprotectin predicts mucosal healing in patients with ulcerative colitis treated with biological therapies: a prospective study L Bertani, C Blandizzi, MG Mumolo, L Ceccarelli, E Albano, G Tapete, ... Clinical and Translational Gastroenterology 11 (5), e00174, 2020 | 41 | 2020 |
| Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment L Bertani, MG Mumolo, G Tapete, E Albano, GB Svizzero, F Zanzi, ... European journal of gastroenterology & hepatology 32 (9), 1091-1098, 2020 | 39 | 2020 |
| Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients L Bertani, L Baglietto, L Antonioli, M Fornai, G Tapete, E Albano, ... British journal of clinical pharmacology 86 (7), 1296-1305, 2020 | 36 | 2020 |
| Effectiveness and safety of nonmedical switch from adalimumab originator to SB5 biosimilar in patients with inflammatory bowel diseases: twelve-month follow-up from the TABLET … G Tapete, L Bertani, A Pieraccini, EN Lynch, M Giannotta, R Morganti, ... Inflammatory Bowel Diseases 28 (1), 62-69, 2022 | 25 | 2022 |
| Overlap of GERD and gastrointestinal functional disorders. N De Bortoli, V Natali, S Melissari, N Simonetti, G Tapete, S Marchi Minerva gastroenterologica e dietologica 63 (3), 205-220, 2017 | 16 | 2017 |
| Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases. L Bertani, L Antonioli, M Fornai, G Tapete, S Marchi, C Blandizzi, F Costa Minerva gastroenterologica e dietologica 65 (4), 298-308, 2019 | 12 | 2019 |
| Clinical outcomes with long-term sorafenib treatment of patients with hepatocellular carcinoma: a multicenter real-life study R Sacco, A Granito, I Bargellini, T Zolfino, C Saitta, L Marzi, G Tapete, ... Future Oncology 14 (29), 3049-3058, 2018 | 10 | 2018 |
| Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study D Pugliese, G Privitera, F Rogai, A Variola, A Viola, L Laterza, ... UEG Journal 9 (1), 102-109, 2021 | 9 | 2021 |
| Corticosteroid treatment at diagnosis: an analysis of relapses, disease extension, and colectomy rate in ulcerative colitis L Bertani, G Bodini, MG Mumolo, N de Bortoli, L Ceccarelli, L Frazzoni, ... Digestive Diseases and Sciences 65, 2397-2402, 2020 | 8 | 2020 |
| P. 07.6 LOW-FODMAPS DIET IMPROVES INTESTINAL SYMPTOMS IN IBD PATIENTS WITH DISEASE REMISSION: RANDOMIZED CASE-CONTROL STUDY G Tapete, N De Bortoli, L Ceccarelli, MG Mumolo, E Vinci, E Albano, ... Digestive and liver disease 50 (2), e195, 2018 | 4 | 2018 |
| P. 06.16 LOW-VERSUS HIGH-FODMAPS DIET IN CONTROLLING RESIDUAL ABDOMINAL SYMPTOMS IN INFLAMMATORY BOWEL DISEASE PATIENTS: A RANDOMIZED STUDY WITH CROSSING OVER G Tapete, L Ceccarelli, N De Bortoli, L Bertani, E Albano, GB Svizzero, ... Digestive and Liver Disease 51, e219, 2019 | 2 | 2019 |
| P. 07.14 management of inflammatory bowel disease during pregnancy: a single center experience G Laino, MG Mumolo, L Ceccarelli, A Carmignani, N De Bortoli, ... Digestive and Liver Disease 50 (2), e199, 2018 | 2 | 2018 |
| P598 Mucosal and transmural healing during anti-TNF therapy. Is fecal calprotectin a marker of therapeutic response? L Bertani, L Ceccarelli, N de Bortoli, E Albano, G Tapete, G Laino, ... Journal of Crohn's and Colitis 11 (suppl_1), S385-S385, 2017 | 2 | 2017 |
| P. 06.9 TWO NEW PROGNOSTIC MARKERS OF MUCOSAL HEALING IN PATIENTS TREATED WITH ANTI-TNF FOR ULCERATIVE COLITIS: THE NEUTROPHIL-TO-LYMPHOCYTE-RATIO AND THE PLATELET-TO … L Bertani, N De Bortoli, G Tapete, E Albano, R Mazzanti, MG Mumolo, ... Digestive and Liver Disease 51, e216, 2019 | 1 | 2019 |
